APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

RNA Synthesis

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global RNA Synthesis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17423252034 June 2026198 pages

Choose your research edition.

Industry ResearchRNA Synthesis Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA Synthesis Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal RNA Synthesis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA Synthesis Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal RNA Synthesis Market Analysis and Forecast 2026-2032245 pages · $4,950 USD

Market perspective

The global RNA Synthesis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RNA Synthesis include GenScript, Hokkaido System Science, Bio-Synthesis, IDT, Thermo Fisher Scientific, Genewiz, Gene Universal, TriLink BioTechnologies and GE Healthcare Dharmacon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global RNA Synthesis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RNA Synthesis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RNA Synthesis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the RNA Synthesis market size, projected growth trends, production technologies, key applications, and end-use industries.

RNA Synthesis Segment by Company

GenScript

Hokkaido System Science

Bio-Synthesis

IDT

Thermo Fisher Scientific

Genewiz

Gene Universal

TriLink BioTechnologies

GE Healthcare Dharmacon

ChemGenes

Creative Biolabs

Glen Research

VeliterBio

Creative Biogene

Merck

Eurofins Scientific

RNA Synthesis Segment by Type

mRNA Synthesis

tRNA Synthesis

rRNA Synthesis

siRNA Synthesis

RNA Synthesis Segment by Application

Biomedical Science

Pharmaceutical

Others

RNA Synthesis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Synthesis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of RNA Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RNA Synthesis industry.

Chapter 3: Detailed analysis of RNA Synthesis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA Synthesisrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RNA Synthesis Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of mRNA Synthesis Table 3. Key Players of tRNA Synthesis Table 4. Key Players of rRNA Synthesis Table 3. Key Players of siRNA Synthesis Table 4. Global RNA Synthesis Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biomedical Science Table 6. Key Players of Pharmaceutical Table 7. Key Players of Others Table 8. Global RNA Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global RNA Synthesis Market Size by Region (2021-2026) & (US$ Million) Table 10. Global RNA Synthesis Market Share by Region (2021-2026) Table 11. Global RNA Synthesis Market Size by Region (2027-2032) & (US$ Million) Table 12. Global RNA Synthesis Market Share by Region (2027-2032) Table 13. RNA Synthesis Industry Trends Table 14. RNA Synthesis Industry Drivers Table 15. RNA Synthesis Industry Opportunities and Challenges Table 16. RNA Synthesis Industry Restraints Table 17. Global RNA Synthesis Revenue by Company (US$ Million) & (2021-2026) Table 18. Global RNA Synthesis Revenue Market Share by Company (2021-2026) Table 19. Global RNA Synthesis Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global RNA Synthesis Key Company Head Office and Area Served Table 21. Global RNA Synthesis Company, Product Type & Application Table 22. Global RNA Synthesis Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global RNA Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global RNA Synthesis Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global RNA Synthesis Market Size by Type (2021-2026) & (US$ Million) Table 27. Global RNA Synthesis Market Size by Type (2027-2032) & (US$ Million) Table 28. Global RNA Synthesis Revenue Market Share by Type (2021-2026) Table 29. Global RNA Synthesis Revenue Market Share by Type (2027-2032) Table 30. Global RNA Synthesis Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global RNA Synthesis Market Size by Application (2021-2026) & (US$ Million) Table 32. Global RNA Synthesis Market Size by Application (2027-2032) & (US$ Million) Table 33. Global RNA Synthesis Revenue Market Share by Application (2021-2026) Table 34. Global RNA Synthesis Revenue Market Share by Application (2027-2032) Table 35. GenScript Company Information Table 36. GenScript Business Overview Table 37. GenScript RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. GenScript RNA Synthesis Product Portfolio Table 39. GenScript Recent Development Table 40. Hokkaido System Science Company Information Table 41. Hokkaido System Science Business Overview Table 42. Hokkaido System Science RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Hokkaido System Science RNA Synthesis Product Portfolio Table 44. Hokkaido System Science Recent Development Table 45. Bio-Synthesis Company Information Table 46. Bio-Synthesis Business Overview Table 47. Bio-Synthesis RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bio-Synthesis RNA Synthesis Product Portfolio Table 49. Bio-Synthesis Recent Development Table 50. IDT Company Information Table 51. IDT Business Overview Table 52. IDT RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. IDT RNA Synthesis Product Portfolio Table 54. IDT Recent Development Table 55. Thermo Fisher Scientific Company Information Table 56. Thermo Fisher Scientific Business Overview Table 57. Thermo Fisher Scientific RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Thermo Fisher Scientific RNA Synthesis Product Portfolio Table 59. Thermo Fisher Scientific Recent Development Table 60. Genewiz Company Information Table 61. Genewiz Business Overview Table 62. Genewiz RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Genewiz RNA Synthesis Product Portfolio Table 64. Genewiz Recent Development Table 65. Gene Universal Company Information Table 66. Gene Universal Business Overview Table 67. Gene Universal RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Gene Universal RNA Synthesis Product Portfolio Table 69. Gene Universal Recent Development Table 70. TriLink BioTechnologies Company Information Table 71. TriLink BioTechnologies Business Overview Table 72. TriLink BioTechnologies RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. TriLink BioTechnologies RNA Synthesis Product Portfolio Table 74. TriLink BioTechnologies Recent Development Table 75. GE Healthcare Dharmacon Company Information Table 76. GE Healthcare Dharmacon Business Overview Table 77. GE Healthcare Dharmacon RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. GE Healthcare Dharmacon RNA Synthesis Product Portfolio Table 79. GE Healthcare Dharmacon Recent Development Table 80. ChemGenes Company Information Table 81. ChemGenes Business Overview Table 82. ChemGenes RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. ChemGenes RNA Synthesis Product Portfolio Table 84. ChemGenes Recent Development Table 85. Creative Biolabs Company Information Table 86. Creative Biolabs Business Overview Table 87. Creative Biolabs RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Creative Biolabs RNA Synthesis Product Portfolio Table 89. Creative Biolabs Recent Development Table 90. Glen Research Company Information Table 91. Glen Research Business Overview Table 92. Glen Research RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Glen Research RNA Synthesis Product Portfolio Table 94. Glen Research Recent Development Table 95. VeliterBio Company Information Table 96. VeliterBio Business Overview Table 97. VeliterBio RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. VeliterBio RNA Synthesis Product Portfolio Table 99. VeliterBio Recent Development Table 100. Creative Biogene Company Information Table 101. Creative Biogene Business Overview Table 102. Creative Biogene RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Creative Biogene RNA Synthesis Product Portfolio Table 104. Creative Biogene Recent Development Table 105. Merck Company Information Table 106. Merck Business Overview Table 107. Merck RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Merck RNA Synthesis Product Portfolio Table 109. Merck Recent Development Table 110. Eurofins Scientific Company Information Table 111. Eurofins Scientific Business Overview Table 112. Eurofins Scientific RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Eurofins Scientific RNA Synthesis Product Portfolio Table 114. Eurofins Scientific Recent Development Table 115. North America RNA Synthesis Market Size by Type (2021-2026) & (US$ Million) Table 116. North America RNA Synthesis Market Size by Type (2027-2032) & (US$ Million) Table 117. North America RNA Synthesis Market Size by Application (2021-2026) & (US$ Million) Table 118. North America RNA Synthesis Market Size by Application (2027-2032) & (US$ Million) Table 119. North America RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America RNA Synthesis Market Size by Country (2021-2026) Table 121. North America RNA Synthesis Market Size by Country (2027-2032) Table 122. Europe RNA Synthesis Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe RNA Synthesis Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe RNA Synthesis Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe RNA Synthesis Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe RNA Synthesis Market Size by Country (2021-2026) Table 128. Europe RNA Synthesis Market Size by Country (2027-2032) Table 129. China RNA Synthesis Market Size by Type (2021-2026) & (US$ Million) Table 130. China RNA Synthesis Market Size by Type (2027-2032) & (US$ Million) Table 131. China RNA Synthesis Market Size by Application (2021-2026) & (US$ Million) Table 132. China RNA Synthesis Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia RNA Synthesis Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia RNA Synthesis Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia RNA Synthesis Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia RNA Synthesis Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia RNA Synthesis Market Size by Country (2021-2026) Table 139. Asia RNA Synthesis Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa RNA Synthesis Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa RNA Synthesis Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa RNA Synthesis Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa RNA Synthesis Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa RNA Synthesis Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa RNA Synthesis Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. RNA Synthesis Product Image Figure 2. Global RNA Synthesis Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global RNA Synthesis Market Share by Type: 2025 VS 2032 Figure 4. mRNA Synthesis Image Figure 5. tRNA Synthesis Image Figure 6. rRNA Synthesis Image Figure 7. siRNA Synthesis Image Figure 8. Global RNA Synthesis Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global RNA Synthesis Market Share by Application: 2025 VS 2032 Figure 10. Biomedical Science Image Figure 11. Pharmaceutical Image Figure 12. Others Image Figure 13. Global RNA Synthesis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 15. Global RNA Synthesis Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global RNA Synthesis Market Share by Players in 2025 Figure 18. Global Top 5 and 10 RNA Synthesis Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global RNA Synthesis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global RNA Synthesis Revenue Market Share by Type (2021-2032) Figure 22. Global RNA Synthesis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global RNA Synthesis Revenue Market Share by Application (2021-2032) Figure 24. North America RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 25. North America RNA Synthesis Market Share by Type (2021-2032) Figure 26. North America RNA Synthesis Market Share by Application (2021-2032) Figure 27. North America RNA Synthesis Market Share by Country (2021-2032) Figure 28. United States RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 29. Canada RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 30. Mexico RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 31. Europe RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 32. Europe RNA Synthesis Market Share by Type (2021-2032) Figure 33. Europe RNA Synthesis Market Share by Application (2021-2032) Figure 34. Europe RNA Synthesis Market Share by Country (2021-2032) Figure 35. Germany RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 36. France RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 37. U.K. RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 38. Italy RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 39. Russia RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 41. China RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 42. China RNA Synthesis Market Share by Type (2021-2032) Figure 43. China RNA Synthesis Market Share by Application (2021-2032) Figure 44. Asia RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 45. Asia RNA Synthesis Market Share by Type (2021-2032) Figure 46. Asia RNA Synthesis Market Share by Application (2021-2032) Figure 47. Asia RNA Synthesis Market Share by Country (2021-2032) Figure 48. Japan RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 49. South Korea RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 52. India RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 53. Australia RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa RNA Synthesis Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa RNA Synthesis Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa RNA Synthesis Market Share by Country (2021-2032) Figure 58. Brazil RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 59. South Africa RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 61. Turkey RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 62. Argentina RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 63. UAE RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 64. Egypt RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 65. Chile RNA Synthesis Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • mRNA Synthesis
  • tRNA Synthesis
  • rRNA Synthesis
  • siRNA Synthesis
Applications
  • Biomedical Science
  • Pharmaceutical
  • Others
Companies covered
  • GenScript
  • Hokkaido System Science
  • Bio-Synthesis
  • IDT
  • Thermo Fisher Scientific
  • Genewiz
  • Gene Universal
  • TriLink BioTechnologies
  • GE Healthcare Dharmacon
  • ChemGenes
  • Creative Biolabs
  • Glen Research
  • VeliterBio
  • Creative Biogene
  • Merck
  • Eurofins Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global RNA Synthesis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 mRNA Synthesis
  5. 1.2.3 tRNA Synthesis
  6. 1.2.4 rRNA Synthesis
  7. 1.2.5 siRNA Synthesis
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global RNA Synthesis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Biomedical Science
  11. 1.3.3 Pharmaceutical
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global RNA Synthesis Growth Trends by Region
  15. 1.5.1 Global RNA Synthesis Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 RNA Synthesis Market Size by Region (2021-2026)
  17. 1.5.3 RNA Synthesis Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global RNA Synthesis Market Dynamics
  1. 2.1 RNA Synthesis Industry Trends
  2. 2.2 RNA Synthesis Industry Drivers
  3. 2.3 RNA Synthesis Industry Opportunities and Challenges
  4. 2.4 RNA Synthesis Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global RNA Synthesis Revenue by Company (2021-2026)
  2. 3.2 Global RNA Synthesis Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global RNA Synthesis Key Company Head office and Area Served
  4. 3.4 Global RNA Synthesis Company, Product Type & Application
  5. 3.5 Global RNA Synthesis Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global RNA Synthesis Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 RNA Synthesis Players Market Share by Revenue in 2025
  9. 3.6.3 2025 RNA Synthesis Tier 1, Tier 2, and Tier 3
4 RNA Synthesis Market by Type
  1. 4.1 Global RNA Synthesis Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global RNA Synthesis Market Size by Type (2021-2032)
  3. 4.3 Global RNA Synthesis Market Size Share by Type (2021-2032)
5 RNA Synthesis Market by Application
  1. 5.1 Global RNA Synthesis Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global RNA Synthesis Market Size by Application (2021-2032)
  3. 5.3 Global RNA Synthesis Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GenScript
  2. 6.1.1 GenScript Company Information
  3. 6.1.2 GenScript Business Overview
  4. 6.1.3 GenScript RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GenScript RNA Synthesis Product Portfolio
  6. 6.1.5 GenScript Recent Developments
  7. 6.2 Hokkaido System Science
  8. 6.2.1 Hokkaido System Science Company Information
  9. 6.2.2 Hokkaido System Science Business Overview
  10. 6.2.3 Hokkaido System Science RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Hokkaido System Science RNA Synthesis Product Portfolio
  12. 6.2.5 Hokkaido System Science Recent Developments
  13. 6.3 Bio-Synthesis
  14. 6.3.1 Bio-Synthesis Company Information
  15. 6.3.2 Bio-Synthesis Business Overview
  16. 6.3.3 Bio-Synthesis RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bio-Synthesis RNA Synthesis Product Portfolio
  18. 6.3.5 Bio-Synthesis Recent Developments
  19. 6.4 IDT
  20. 6.4.1 IDT Company Information
  21. 6.4.2 IDT Business Overview
  22. 6.4.3 IDT RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 IDT RNA Synthesis Product Portfolio
  24. 6.4.5 IDT Recent Developments
  25. 6.5 Thermo Fisher Scientific
  26. 6.5.1 Thermo Fisher Scientific Company Information
  27. 6.5.2 Thermo Fisher Scientific Business Overview
  28. 6.5.3 Thermo Fisher Scientific RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Thermo Fisher Scientific RNA Synthesis Product Portfolio
  30. 6.5.5 Thermo Fisher Scientific Recent Developments
  31. 6.6 Genewiz
  32. 6.6.1 Genewiz Company Information
  33. 6.6.2 Genewiz Business Overview
  34. 6.6.3 Genewiz RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Genewiz RNA Synthesis Product Portfolio
  36. 6.6.5 Genewiz Recent Developments
  37. 6.7 Gene Universal
  38. 6.7.1 Gene Universal Company Information
  39. 6.7.2 Gene Universal Business Overview
  40. 6.7.3 Gene Universal RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Gene Universal RNA Synthesis Product Portfolio
  42. 6.7.5 Gene Universal Recent Developments
  43. 6.8 TriLink BioTechnologies
  44. 6.8.1 TriLink BioTechnologies Company Information
  45. 6.8.2 TriLink BioTechnologies Business Overview
  46. 6.8.3 TriLink BioTechnologies RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 TriLink BioTechnologies RNA Synthesis Product Portfolio
  48. 6.8.5 TriLink BioTechnologies Recent Developments
  49. 6.9 GE Healthcare Dharmacon
  50. 6.9.1 GE Healthcare Dharmacon Company Information
  51. 6.9.2 GE Healthcare Dharmacon Business Overview
  52. 6.9.3 GE Healthcare Dharmacon RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 GE Healthcare Dharmacon RNA Synthesis Product Portfolio
  54. 6.9.5 GE Healthcare Dharmacon Recent Developments
  55. 6.10 ChemGenes
  56. 6.10.1 ChemGenes Company Information
  57. 6.10.2 ChemGenes Business Overview
  58. 6.10.3 ChemGenes RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ChemGenes RNA Synthesis Product Portfolio
  60. 6.10.5 ChemGenes Recent Developments
  61. 6.11 Creative Biolabs
  62. 6.11.1 Creative Biolabs Company Information
  63. 6.11.2 Creative Biolabs Business Overview
  64. 6.11.3 Creative Biolabs RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Creative Biolabs RNA Synthesis Product Portfolio
  66. 6.11.5 Creative Biolabs Recent Developments
  67. 6.12 Glen Research
  68. 6.12.1 Glen Research Company Information
  69. 6.12.2 Glen Research Business Overview
  70. 6.12.3 Glen Research RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Glen Research RNA Synthesis Product Portfolio
  72. 6.12.5 Glen Research Recent Developments
  73. 6.13 VeliterBio
  74. 6.13.1 VeliterBio Company Information
  75. 6.13.2 VeliterBio Business Overview
  76. 6.13.3 VeliterBio RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 VeliterBio RNA Synthesis Product Portfolio
  78. 6.13.5 VeliterBio Recent Developments
  79. 6.14 Creative Biogene
  80. 6.14.1 Creative Biogene Company Information
  81. 6.14.2 Creative Biogene Business Overview
  82. 6.14.3 Creative Biogene RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Creative Biogene RNA Synthesis Product Portfolio
  84. 6.14.5 Creative Biogene Recent Developments
  85. 6.15 Merck
  86. 6.15.1 Merck Company Information
  87. 6.15.2 Merck Business Overview
  88. 6.15.3 Merck RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Merck RNA Synthesis Product Portfolio
  90. 6.15.5 Merck Recent Developments
  91. 6.16 Eurofins Scientific
  92. 6.16.1 Eurofins Scientific Company Information
  93. 6.16.2 Eurofins Scientific Business Overview
  94. 6.16.3 Eurofins Scientific RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Eurofins Scientific RNA Synthesis Product Portfolio
  96. 6.16.5 Eurofins Scientific Recent Developments
7 North America
  1. 7.1 North America RNA Synthesis Market Size (2021-2032)
  2. 7.2 North America RNA Synthesis Market Size by Type
  3. 7.2.1 North America RNA Synthesis Market Size by Type (2021-2026)
  4. 7.2.2 North America RNA Synthesis Market Size by Type (2027-2032)
  5. 7.2.3 North America RNA Synthesis Market Share by Type (2021-2032)
  6. 7.3 North America RNA Synthesis Market Size by Application
  7. 7.3.1 North America RNA Synthesis Market Size by Application (2021-2026)
  8. 7.3.2 North America RNA Synthesis Market Size by Application (2027-2032)
  9. 7.3.3 North America RNA Synthesis Market Share by Application (2021-2032)
  10. 7.4 North America RNA Synthesis Market Size by Country
  11. 7.4.1 North America RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America RNA Synthesis Market Size by Country (2021-2026)
  13. 7.4.3 North America RNA Synthesis Market Size by Country (2027-2032)
  14. 7.4.4 North America RNA Synthesis Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe RNA Synthesis Market Size (2021-2032)
  2. 8.2 Europe RNA Synthesis Market Size by Type
  3. 8.2.1 Europe RNA Synthesis Market Size by Type (2021-2026)
  4. 8.2.2 Europe RNA Synthesis Market Size by Type (2027-2032)
  5. 8.2.3 Europe RNA Synthesis Market Share by Type (2021-2032)
  6. 8.3 Europe RNA Synthesis Market Size by Application
  7. 8.3.1 Europe RNA Synthesis Market Size by Application (2021-2026)
  8. 8.3.2 Europe RNA Synthesis Market Size by Application (2027-2032)
  9. 8.3.3 Europe RNA Synthesis Market Share by Application (2021-2032)
  10. 8.4 Europe RNA Synthesis Market Size by Country
  11. 8.4.1 Europe RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe RNA Synthesis Market Size by Country (2021-2026)
  13. 8.4.3 Europe RNA Synthesis Market Size by Country (2027-2032)
  14. 8.4.4 Europe RNA Synthesis Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China RNA Synthesis Market Size (2021-2032)
  2. 9.2 China RNA Synthesis Market Size by Type
  3. 9.2.1 China RNA Synthesis Market Size by Type (2021-2026)
  4. 9.2.2 China RNA Synthesis Market Size by Type (2027-2032)
  5. 9.2.3 China RNA Synthesis Market Share by Type (2021-2032)
  6. 9.3 China RNA Synthesis Market Size by Application
  7. 9.3.1 China RNA Synthesis Market Size by Application (2021-2026)
  8. 9.3.2 China RNA Synthesis Market Size by Application (2027-2032)
  9. 9.3.3 China RNA Synthesis Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia RNA Synthesis Market Size (2021-2032)
  2. 10.2 Asia RNA Synthesis Market Size by Type
  3. 10.2.1 Asia RNA Synthesis Market Size by Type (2021-2026)
  4. 10.2.2 Asia RNA Synthesis Market Size by Type (2027-2032)
  5. 10.2.3 Asia RNA Synthesis Market Share by Type (2021-2032)
  6. 10.3 Asia RNA Synthesis Market Size by Application
  7. 10.3.1 Asia RNA Synthesis Market Size by Application (2021-2026)
  8. 10.3.2 Asia RNA Synthesis Market Size by Application (2027-2032)
  9. 10.3.3 Asia RNA Synthesis Market Share by Application (2021-2032)
  10. 10.4 Asia RNA Synthesis Market Size by Country
  11. 10.4.1 Asia RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia RNA Synthesis Market Size by Country (2021-2026)
  13. 10.4.3 Asia RNA Synthesis Market Size by Country (2027-2032)
  14. 10.4.4 Asia RNA Synthesis Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa RNA Synthesis Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa RNA Synthesis Market Size by Type
  3. 11.2.1 South America, Middle East & Africa RNA Synthesis Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa RNA Synthesis Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa RNA Synthesis Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa RNA Synthesis Market Size by Application
  7. 11.3.1 South America, Middle East & Africa RNA Synthesis Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa RNA Synthesis Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa RNA Synthesis Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa RNA Synthesis Market Size by Country
  11. 11.4.1 South America, Middle East & Africa RNA Synthesis Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa RNA Synthesis Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa RNA Synthesis Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa RNA Synthesis Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst